Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
NKTR
$60.55
+2.20%
NKTR
· Nektar Therapeutics
$60.55
+1.31 (+2.20%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.95B
Shares
34.14M
Volume · Sep 30
1.21M
Avg daily vol (3M)
928.13K
All earnings calls
Earnings call · FY2024 Q2
Nektar Therapeutics (NKTR) Q2 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$23.49M
+14.6% YoY
Diluted EPS
-$3.76
Net income
-$52.36M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 9, 2024 · complete as-filed document